Home NDC 0006-3823 CANCIDAS
Product NDC 0006-3823
11-digit product format 000063823
Labeler code 0006
Product ID 0006-3823_42355646-adc3-4d93-b20f-07bd8a2468ac
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name CASPOFUNGIN ACETATE
Dosage form INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route INTRAVENOUS
Labeler Merck Sharp & Dohme LLC
Application NDA021227
Marketing category NDA
Marketing start 2001-01-26
Substance CASPOFUNGIN ACETATE
Active strength 7 mg/mL
Pharmacologic classes Echinocandin Antifungal [EPC], Lipopeptides [CS]
NDC exclude flag No
Listing certified through 2027-12-31
Current FDA listing Yes Source provenance: Browse the complete Orange Book source catalog · source snapshot 44 .
Orange Book products# Current product rows page 1 of 1 · 2 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N021227-001 CANCIDAS CASPOFUNGIN ACETATE 50MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** POWDER / INTRAVENOUS RLD 2001-01-26 N021227-002 CANCIDAS CASPOFUNGIN ACETATE 70MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** POWDER / INTRAVENOUS RLD 2001-01-26
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 3 · 88 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-10-15 13:18:30 2026-09 N021227-001 CANCIDAS 50MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** POWDER / INTRAVENOUS RLD 2001-01-26 c2088c7a36db…2026-10-15 13:18:30 2026-09 N021227-002 CANCIDAS 70MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** POWDER / INTRAVENOUS RLD 2001-01-26 c2088c7a36db…2026-09-14 22:38:34 2026-08 N021227-001 CANCIDAS 50MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** POWDER / INTRAVENOUS RLD 2001-01-26 84e616aacf4f…2026-09-14 22:38:34 2026-08 N021227-002 CANCIDAS 70MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** POWDER / INTRAVENOUS RLD 2001-01-26 84e616aacf4f…2026-08-18 06:07:40 2026-07 N021227-001 CANCIDAS 50MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** POWDER / INTRAVENOUS RLD 2001-01-26 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N021227-002 CANCIDAS 70MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** POWDER / INTRAVENOUS RLD 2001-01-26 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 N021227-001 CANCIDAS 50MG/VIAL POWDER / INTRAVENOUS RLD 2001-01-26 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N021227-002 CANCIDAS 70MG/VIAL POWDER / INTRAVENOUS RLD 2001-01-26 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N021227-001 CANCIDAS 50MG/VIAL POWDER / INTRAVENOUS RLD 2001-01-26 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N021227-002 CANCIDAS 70MG/VIAL POWDER / INTRAVENOUS RLD 2001-01-26 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N021227-001 CANCIDAS 50MG/VIAL POWDER / INTRAVENOUS RLD 2001-01-26 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N021227-002 CANCIDAS 70MG/VIAL POWDER / INTRAVENOUS RLD 2001-01-26 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N021227-001 CANCIDAS 50MG/VIAL POWDER / INTRAVENOUS RLD 2001-01-26 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N021227-002 CANCIDAS 70MG/VIAL POWDER / INTRAVENOUS RLD 2001-01-26 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N021227-001 CANCIDAS 50MG/VIAL POWDER / INTRAVENOUS RLD 2001-01-26 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N021227-002 CANCIDAS 70MG/VIAL POWDER / INTRAVENOUS RLD 2001-01-26 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N021227-001 CANCIDAS 50MG/VIAL POWDER / INTRAVENOUS RLD 2001-01-26 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N021227-002 CANCIDAS 70MG/VIAL POWDER / INTRAVENOUS RLD 2001-01-26 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N021227-001 CANCIDAS 50MG/VIAL POWDER / INTRAVENOUS AP RLD, RS 2001-01-26 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N021227-002 CANCIDAS 70MG/VIAL POWDER / INTRAVENOUS AP RLD, RS 2001-01-26 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N021227-001 CANCIDAS 50MG/VIAL POWDER / INTRAVENOUS AP RLD, RS 2001-01-26 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N021227-002 CANCIDAS 70MG/VIAL POWDER / INTRAVENOUS AP RLD, RS 2001-01-26 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N021227-001 CANCIDAS 50MG/VIAL POWDER / INTRAVENOUS AP RLD, RS 2001-01-26 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N021227-002 CANCIDAS 70MG/VIAL POWDER / INTRAVENOUS AP RLD, RS 2001-01-26 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 N021227-001 CANCIDAS 50MG/VIAL POWDER / INTRAVENOUS AP RLD, RS 2001-01-26 d06236e962d9…2024-10-29 15:01 UTC 2024-10 N021227-002 CANCIDAS 70MG/VIAL POWDER / INTRAVENOUS AP RLD, RS 2001-01-26 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N021227-001 CANCIDAS 50MG/VIAL POWDER / INTRAVENOUS AP RLD, RS 2001-01-26 79d66fd596c7…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N021227-002 CANCIDAS 70MG/VIAL POWDER / INTRAVENOUS AP RLD, RS 2001-01-26 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N021227-001 CANCIDAS 50MG/VIAL POWDER / INTRAVENOUS AP RLD, RS 2001-01-26 301d65b070ca…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N021227-002 CANCIDAS 70MG/VIAL POWDER / INTRAVENOUS AP RLD, RS 2001-01-26 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 N021227-001 CANCIDAS 50MG/VIAL POWDER / INTRAVENOUS AP RLD, RS 2001-01-26 1e350fbaab3a…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 N021227-002 CANCIDAS 70MG/VIAL POWDER / INTRAVENOUS AP RLD, RS 2001-01-26 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 N021227-001 CANCIDAS 50MG/VIAL POWDER / INTRAVENOUS AP RLD, RS 2001-01-26 8072bd15b7f6…2024-05-31 18:47 UTC 2024-05 N021227-002 CANCIDAS 70MG/VIAL POWDER / INTRAVENOUS AP RLD, RS 2001-01-26 8072bd15b7f6…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 N021227-001 CANCIDAS 50MG/VIAL POWDER / INTRAVENOUS AP RLD, RS 2001-01-26 5c6f7cd8ea54…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 N021227-002 CANCIDAS 70MG/VIAL POWDER / INTRAVENOUS AP RLD, RS 2001-01-26 5c6f7cd8ea54…2022-04-08 23:34 UTC 2022-04 N021227-001 CANCIDAS 50MG/VIAL POWDER / INTRAVENOUS AP RLD, RS 2001-01-26 5d02ea3f76ae…2022-04-08 23:34 UTC 2022-04 N021227-002 CANCIDAS 70MG/VIAL POWDER / INTRAVENOUS AP RLD, RS 2001-01-26 5d02ea3f76ae…2022-04-04 05:41 UTC 2022-04 N021227-001 CANCIDAS 50MG/VIAL POWDER / INTRAVENOUS AP RLD, RS 2001-01-26 4b0b4de00fa7…2022-04-04 05:41 UTC 2022-04 N021227-002 CANCIDAS 70MG/VIAL POWDER / INTRAVENOUS AP RLD, RS 2001-01-26 4b0b4de00fa7…
Observed Orange Book normalized TE history# Normalized TE history page 1 of 2 · 68 observed states.
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
Finished product Yes
Brand name base CANCIDAS
Listing expiration 2027-12-31 Active Ingredients# Ingredient, Strength table Ingredient Strength CASPOFUNGIN ACETATE 7 mg/mL
DailyMed Product Concepts# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 0006-3823-10 CANCIDAS 1 in 1 CARTON INJECTION, POWDER, LYOPHILIZED, 1 41 0006-3823-10 CANCIDAS 10.8 mL in 1 VIAL, SINGLE-USE INJECTION, POWDER, LYOPHILIZED, 10.8 41
DailyMed Socrata Ingredients# Ingredient, Type, UNII table Ingredient Type UNII DailyMed label SPL version Uploaded CASPOFUNGIN ACETATE ACTIVE INGREDIENT VUW370O5QE CANCIDAS (CASPOFUNGIN ACETATE) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [MERCK SHARP & DOHME CORP.] 20 CASPOFUNGIN ACTIVE MOIETY F0XDI6ZL63 CANCIDAS (CASPOFUNGIN ACETATE) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [MERCK SHARP & DOHME CORP.] 20 ACETIC ACID INACTIVE INGREDIENT Q40Q9N063P CANCIDAS (CASPOFUNGIN ACETATE) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [MERCK SHARP & DOHME CORP.] 20 MANNITOL INACTIVE INGREDIENT 3OWL53L36A CANCIDAS (CASPOFUNGIN ACETATE) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [MERCK SHARP & DOHME CORP.] 20 SODIUM HYDROXIDE INACTIVE INGREDIENT 55X04QC32I CANCIDAS (CASPOFUNGIN ACETATE) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [MERCK SHARP & DOHME CORP.] 20 SUCROSE INACTIVE INGREDIENT C151H8M554 CANCIDAS (CASPOFUNGIN ACETATE) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [MERCK SHARP & DOHME CORP.] 20
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 0006-3823 CANCIDAS (CASPOFUNGIN ACETATE) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [MERCK SHARP & DOHME LLC] 40 Current NDC, Legacy NDC, 2 package rows 20241018_3bad23a6-09a6-4194-9182-093ed61bc71c.zip
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Marketing start Marketing end Sample Exclude flag Status 0006-3823-10 00006382310 1 VIAL, SINGLE-USE in 1 CARTON (0006-3823-10) / 10.8 mL in 1 VIAL, SINGLE-USE 2001-01-26 0000-00-00 No No Current